Survival in Patients With De Novo Metastatic Prostate Cancer-Reference-Cited by-同舟云学术

Survival in Patients With De Novo Metastatic Prostate Cancer

Published:2024-03-12 Issue:3 Volume:7 Page:e241970
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Schoen Martin W.¹²,Montgomery R. Bruce³⁴⁵,Owens Lukas³⁴,Khan Saira⁶,Sanfilippo Kristen M.¹⁶,Etzioni Ruth B.⁴⁵

Affiliation:

1. Saint Louis Veterans Affairs Medical Center, Saint Louis, Missouri

2. Saint Louis University School of Medicine, Saint Louis, Missouri

3. VA Puget Sound Healthcare System, Washington

4. Fred Hutchinson Cancer Center, Seattle, Washington

5. University of Washington School of Medicine, Seattle

6. Washington University in St Louis School of Medicine, Saint Louis, Missouri

Abstract

This cross-sectional study investigates trends in overall survival among patients with newly diagnosed metastatic prostate cancer in 2 national registries in the United States.

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2815950/schoen_2024_ld_240017_1709153777.04748.pdf

Reference6 articles.

1. Orteronel for metastatic hormone-sensitive prostate cancer: a multicenter, randomized, open-label phase III trial (SWOG-1216).;Agarwal;J Clin Oncol,2022

2. Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial.;Fizazi;Lancet Oncol,2019

3. Changes in survival in de novo metastatic cancer in an era of new medicines.;Luyendijk;J Natl Cancer Inst,2023

4. Survival trend in individuals with de novo metastatic prostate cancer after the introduction of doublet therapy.;Corsini;JAMA Netw Open,2023

5. Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases.;Schoen;Prostate Cancer Prostatic Dis,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Circulating miR-107 as a Potential Biomarker Up-Regulated in Castration-Resistant Prostate Cancer;Non-Coding RNA;2024-08-24